Haemonetics (HAE) Long-Term Deferred Tax (2016 - 2025)
Haemonetics has reported Long-Term Deferred Tax over the past 16 years, most recently at $7.3 million for Q4 2025.
- For Q4 2025, Long-Term Deferred Tax fell 8.39% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, down 8.39%, while the annual FY2025 figure was $7.8 million, 0.83% up from the prior year.
- Long-Term Deferred Tax for Q4 2025 was $7.3 million at Haemonetics, down from $7.6 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $9.4 million in Q2 2024 and troughed at $4.3 million in Q4 2022.
- A 5-year average of $6.4 million and a median of $6.1 million in 2021 define the central range for Long-Term Deferred Tax.
- Biggest five-year swings in Long-Term Deferred Tax: decreased 29.39% in 2022 and later surged 92.18% in 2024.
- Year by year, Long-Term Deferred Tax stood at $6.1 million in 2021, then dropped by 20.15% to $4.8 million in 2022, then grew by 4.71% to $5.1 million in 2023, then soared by 57.79% to $8.0 million in 2024, then dropped by 8.39% to $7.3 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for HAE at $7.3 million in Q4 2025, $7.6 million in Q3 2025, and $7.8 million in Q2 2025.